vs

Side-by-side financial comparison of Sunshine Biopharma Inc. (SBFM) and WESTPORT FUEL SYSTEMS INC. (WPRT). Click either name above to swap in a different company.

WESTPORT FUEL SYSTEMS INC. is the larger business by last-quarter revenue ($12.5M vs $8.6M, roughly 1.5× Sunshine Biopharma Inc.). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -274.8%, a 249.8% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -11.4%). Sunshine Biopharma Inc. produced more free cash flow last quarter ($-1.6M vs $-6.4M).

Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.

Westport Innovations is a company that develops alternative fuel, low-emissions technologies to allow engines to operate on clean-burning fuels such as compressed natural gas (CNG), liquefied natural gas (LNG), hydrogen and biofuels such as landfill gas. Headquartered in Vancouver, British Columbia, Canada, where the company was founded, Westport also has facilities in France, Sweden, Italy, China, Australia and the United States.

SBFM vs WPRT — Head-to-Head

Bigger by revenue
WPRT
WPRT
1.5× larger
WPRT
$12.5M
$8.6M
SBFM
Growing faster (revenue YoY)
SBFM
SBFM
+0.8% gap
SBFM
-10.6%
-11.4%
WPRT
Higher net margin
SBFM
SBFM
249.8% more per $
SBFM
-25.0%
-274.8%
WPRT
More free cash flow
SBFM
SBFM
$4.8M more FCF
SBFM
$-1.6M
$-6.4M
WPRT

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
SBFM
SBFM
WPRT
WPRT
Revenue
$8.6M
$12.5M
Net Profit
$-2.1M
$-34.3M
Gross Margin
35.3%
6.7%
Operating Margin
-20.9%
-8.1%
Net Margin
-25.0%
-274.8%
Revenue YoY
-10.6%
-11.4%
Net Profit YoY
0.8%
-690.4%
EPS (diluted)
$-1.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SBFM
SBFM
WPRT
WPRT
Q4 25
$8.6M
Q3 25
$9.4M
Q2 25
$9.4M
$12.5M
Q1 25
$8.9M
Q4 24
$9.6M
Q3 24
$8.4M
$4.9M
Q2 24
$9.3M
$14.1M
Q1 24
$7.5M
Net Profit
SBFM
SBFM
WPRT
WPRT
Q4 25
$-2.1M
Q3 25
$-883.8K
Q2 25
$-1.8M
$-34.3M
Q1 25
$-1.2M
Q4 24
$-2.2M
Q3 24
$-1.2M
$-3.9M
Q2 24
$-494.3K
$5.8M
Q1 24
$-1.3M
Gross Margin
SBFM
SBFM
WPRT
WPRT
Q4 25
35.3%
Q3 25
32.6%
Q2 25
36.4%
6.7%
Q1 25
30.7%
Q4 24
32.2%
Q3 24
34.0%
13.6%
Q2 24
25.3%
16.7%
Q1 24
31.2%
Operating Margin
SBFM
SBFM
WPRT
WPRT
Q4 25
-20.9%
Q3 25
-11.5%
Q2 25
-21.8%
-8.1%
Q1 25
-14.6%
Q4 24
-21.7%
Q3 24
-13.1%
-43.9%
Q2 24
-13.6%
-54.9%
Q1 24
-17.9%
Net Margin
SBFM
SBFM
WPRT
WPRT
Q4 25
-25.0%
Q3 25
-9.4%
Q2 25
-18.8%
-274.8%
Q1 25
-13.3%
Q4 24
-22.5%
Q3 24
-14.2%
-79.3%
Q2 24
-5.3%
41.2%
Q1 24
-17.0%
EPS (diluted)
SBFM
SBFM
WPRT
WPRT
Q4 25
Q3 25
$-0.54
Q2 25
$-0.82
$-1.98
Q1 25
$-0.44
Q4 24
$49.77
Q3 24
$-11.61
$-0.22
Q2 24
$-43.48
$0.34
Q1 24
$-2.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SBFM
SBFM
WPRT
WPRT
Cash + ST InvestmentsLiquidity on hand
$6.1M
Total DebtLower is stronger
$977.0K
Stockholders' EquityBook value
$23.0M
$108.9M
Total Assets
$30.1M
$272.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SBFM
SBFM
WPRT
WPRT
Q4 25
Q3 25
Q2 25
$6.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
SBFM
SBFM
WPRT
WPRT
Q4 25
Q3 25
Q2 25
$977.0K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
SBFM
SBFM
WPRT
WPRT
Q4 25
$23.0M
Q3 25
$24.2M
Q2 25
$25.7M
$108.9M
Q1 25
$22.7M
Q4 24
$23.5M
Q3 24
$25.0M
$149.3M
Q2 24
$23.5M
$151.5M
Q1 24
$24.8M
Total Assets
SBFM
SBFM
WPRT
WPRT
Q4 25
$30.1M
Q3 25
$31.5M
Q2 25
$32.0M
$272.1M
Q1 25
$29.2M
Q4 24
$30.6M
Q3 24
$30.1M
Q2 24
$29.3M
Q1 24
$31.9M
Debt / Equity
SBFM
SBFM
WPRT
WPRT
Q4 25
Q3 25
Q2 25
0.01×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SBFM
SBFM
WPRT
WPRT
Operating Cash FlowLast quarter
$-1.6M
$-5.6M
Free Cash FlowOCF − Capex
$-1.6M
$-6.4M
FCF MarginFCF / Revenue
-18.9%
-51.6%
Capex IntensityCapex / Revenue
0.0%
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SBFM
SBFM
WPRT
WPRT
Q4 25
$-1.6M
Q3 25
$-727.8K
Q2 25
$-1.3M
$-5.6M
Q1 25
$-1.7M
Q4 24
$-3.4M
Q3 24
$-1.4M
$-11.7M
Q2 24
$-4.6M
$1.5M
Q1 24
$-3.2M
Free Cash Flow
SBFM
SBFM
WPRT
WPRT
Q4 25
$-1.6M
Q3 25
$-735.8K
Q2 25
$-1.4M
$-6.4M
Q1 25
$-1.7M
Q4 24
$-3.5M
Q3 24
$-1.9M
$-11.9M
Q2 24
$-5.6M
$262.0K
Q1 24
$-3.2M
FCF Margin
SBFM
SBFM
WPRT
WPRT
Q4 25
-18.9%
Q3 25
-7.8%
Q2 25
-15.2%
-51.6%
Q1 25
-19.3%
Q4 24
-36.6%
Q3 24
-22.2%
-243.4%
Q2 24
-59.7%
1.9%
Q1 24
-43.1%
Capex Intensity
SBFM
SBFM
WPRT
WPRT
Q4 25
0.0%
Q3 25
0.1%
Q2 25
1.7%
6.6%
Q1 25
0.1%
Q4 24
1.1%
Q3 24
6.1%
3.8%
Q2 24
10.5%
8.9%
Q1 24
0.8%
Cash Conversion
SBFM
SBFM
WPRT
WPRT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons